logo
THE ROLE OF REPEAT TRANSPLANTATION OF HAEMOPOIETIC STEM CELLS AND ADOPTIVE IMMUNOTHERAPY IN TREATMENT OF LEUKAEMIA RELAPSING FOLLOWING ALLOGENEIC TRANSPLANTATION
Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferon
IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation
Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy
The outcome of children requiring admission to an intensive care unit following bone marrow transplantation
Cytomegalovirus infection in recipients of related and unrelated donor bone marrow transplants
Randomized clinical study comparing aggressive chemotherapy with or without G-CSF support for high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia evolving from MDS
Myelofibrosis with myeloid metaplasia in young individuals
Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma
Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease
MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders
Liposomal vincristine for the treatment of human acute lymphoblastic leukaemia in severe combined immunodeficient (SCID) mice
Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia
Critical study of prognostic factors in childhood acute lymphoblastic leukaemia
Expression of the leptin receptor in human leukaemic blast cells
Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells
Aberrant TSG101 transcripts in acute myeloid leukaemia
Chronic myelogenous leukaemia CD34+ cells exit G0/G 1 phases of cell cycle more rapidly than normal marrow CD34+ cells
Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR
The haemopoietic effects of thrombopoietin administered post-myelosuppressive carboplatin therapy compared to either pre- and post- or pre-chemotherapy
Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma
Two M-components in a single cell lineage in a patient with a dual isotype secretory B-cell tumour
Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow biopsies of patients with Waldenstrom's macroglobulinaemia
Granulocyte colony-stimulating factor-induced dephosphorylation of a 45 kD cytosolic protein in HL-60 cells differentiating into neutrophils
Associations between TGF-beta 1 receptors in human bone marrow stromal cells
K-252a-induced polyploidization and differentiation of a human megakaryocytic cell line, Meg-J
Recombinant human natural autoantibodies against GPIIb/IIIa inhibit binding of autoantibodies from patients with AITP
Novel point mutations in the alpha IIb subunit (Phe289 [arrow right] Ser, Glu324 [arrow right] Lys and Gln747 [arrow right] Pro) causing thrombasthenic phenotypes in four Japanese patients
IgG from patients with antiphospholipid syndrome binds to platelets without induction of platelet activation
Inter-individual variability in Ca2+ signalling in platelets from healthy volunteers
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia
ABSENCE OF HTLV-I/II IN T-PROLYMPHOCYTIC LEUKAEMIA
ABSENCE OF HTLV-I/II IN T-PROLYMPHOCYTIC LEUKAEMIA
THE PHILADELPHIA CHROMOSOME AS A SECONDARY ABNORMALITY IN TWO CASES OF ACUTE MYELOID LEUKEMIA
SURVEY OF THE USE OF PLATELET TRANSFUSIONS IN CENTRES PARTICIPATING IN MRC LEUKAEMIA TRIALS
IMPROVEMENT OF ADULT T-CELL LYMPHOMA/LEUKAEMIA BY ANTIVIRAL DRUGS INCLUDING FOSCARNET
Red Cell Transfusion